Inappropriately repeated lipid tests in a tertiary hospital in Greece: The magnitude and cost of the phenomenon

Hippokratia

Volumn 16, Issue 3, 2012, Pages 261-266

  Iliadi, V ^a   Kastanioti, C ^b   Maropoulos, G ^a   Niakas, D ^c  

^a KAT HOSPITAL   (Greece)

^b TECHNOLOGICAL EDUCATIONAL INSTITUTE OF KALAMATA   (Greece)

^c HELLENIC OPEN UNIVERSITY   (Greece)

Author keywords

Cholesterol; Excessive laboratory use; Inappropriate test repeat; Lipids; Triglycerides

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COST BENEFIT ANALYSIS; GREECE; HOSPITAL COST; HOSPITAL PATIENT; HUMAN; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PHYSICIAN ATTITUDE; REVIEW; RISK ASSESSMENT; RISK FACTOR; TERTIARY HEALTH CARE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84868131685     PISSN: 11084189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Miyakis S, Karamanof G, Liontos M, Mountokalakis TD. Factors contributing to inappropriate ordering of tests in an academic medical department and the effect of an educational feedbackstrategy. Postgrad Med J. 2006; 82: 823-829
2. Walraven C, Raymond M. Population-based study of repeat laboratory testing. Clin Chem. 2003; 49: 1997-2005
3. Werner M. Appropriate utilization and cost control of the hospital laboratory: panel testing and repeat orders. Clinica Chemica Acta. 1995; 233: 1-17
4. Walraven C, Naylor CD. Do we know what inappropriate laboratory utilization is? A systematic review of laboratory clinical audits. JAMA 1998; 280: 550-558
5. Benson ES. The responsible use of the clinical laboratory. Clin Biochem. 1986; 19: 262-270
6. Robinson A. Rationale for cost-effective laboratory medicine.Clin Microbiol Rev. 1994; 7: 185-199
7. Rix DB, Stump G. Is there duplication of diagnostic test results? Can Med Assoc J. 1975; 112: 237-238, 241, 244
8. Ezzie ME, Aberegg SK, O'Brien JM Jr. Laboratory testing in the intensive care unit. Crit Care Clin. 2007; 23: 435-465.
9. Valenstein P, Leiken A, Lehman C. Test-ordering by multiple physicians increases unnecessary laboratory examinations. Arch Pathol Lab Med. 1988; 112: 238-241
10. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III). Final report. NIH Publication 2002; No 02-5215
11. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III). Executive Summary. NIH Publication 2001; No 01-3670
12. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT,Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines, J Am Coll Cardiol. 2004; 44: 720-732
13. Rifai N, Warnick G, Remaley A. Lipids, lipoproteins, apolipoproteins, and other cardiovascular risk factors. In Tietz Fundamentals of clinical chemistry, 6th ed. &'*+<$> Saunders- Elsevier;2008, chapter 23, p. 402-431
14. Fletcher B, Berra K, Ades P, Braun LT, Burke LE, Durstine JL, et al. Managing abnormal blood lipids: a collaborative approach. Circulation. 2005; 112: 3184-3209
15. Ontario Association of Medical Laboratories. Guideline for adult lipid testing. Community Laboratory Guidelines 2008, www.oaml.com
16. American Diabetes association. Standards of medical care in diabetes- 2008. Diabetes Care. 2008; 31: S12-S54
17. American Diabetes Association. Treating high cholesterol in people with diabetes (toolkit No. 17), www.diabetes.org
18. American Diabetes Association. Management of dyslipidemia in adults with diabetes. Diabetes Care. 2002; 25: S74-S77
19. National Institute for Clinical Excellence. Clinical guideline H, Management of blood pressure and blood lipids. NHS 2002, www.nice.org.uk
20. Kwan BC, Krokenberg F, Beddhu S, Cheung AK. Lipoprotein metabolism and lipid management in chronic kidney disease. J Am Soc Nephrol. 2007; 18: 1246-1261
21. British Columbia Guidelines and Protocols Advisory Committee. Identification, evaluation and management of patients with chronic kidney disease. www.healthservices.gov.bc.ca/cdm
22. Kasiske BL, Vazquez MA, Harmon WE, Brown RS, Danovitch GM, Gaston RS, et al. Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol. 2000; 11: S1-S86
23. Perrea DN, Moulakakis KG, Poulakou MV, Vlachos IS, Nikiteas N, Kostakis A. Correlation between lipid abnormalities and immunosuppressive therapy in renal transplant recipients with stable renal function. Int Urol Nephrol 2008; 40: 521-527
24. Ligtenberg G, Hené RJ, Blankestijn PJ, Koomans HA. Cardiovascular risk factors in renal transplant patients: cyclosporine A versus tacrolimus. J Am Soc Nephrol 2001; 12: 368-373
25. Viola RA, Abbott KC, Welch PG, McMillan RJ, Sheikh AM, Yuan CM. A multidisciplinary program for achieving lipid goals in chronic hemodialysis patients. BMC Nephrol. 2002; 3: 9
26. Suver DJ. Management Accounting for Healthcare Organisations, Healthcare Financial Management Association and Pluribus Press, Chicago, 1992
27. Finkler SA. The dinstiction between costs and charges. Ann Intern Med 1982; 96: 102-109
28. Aletras V, Kontodimopoulos N, Zagouldoudis A, Niakas D. The short-term effect on technical and scale efficiency of establishing regional health systems and general management in Greek NHS hospitals. Health Policy. 2007; 83: 236-245
29. Serb C. The profit potential of hospital labs. Hosp Health Netw. 2008; 82: 46-48
30. Charuruks N, Chamnapai S, Seublinvog T. Cost analysis of laboratory tests: a study of the central laboratory of King Chulalongkorn Memorial Hospital. J Med Assoc Thai. 2004; 87: 955-963
31. Calderon-Margalit R, Mor-Yosef S, Mayer M, Adler B, Shapira SC. An administrative intervention to improve the utilization of laboratory tests within a university hospital. Int J Qual Health Care. 2005; 17: 243-248
32. Gortmaker SL, Bickford AF, Matewson HO, Dumbaugh K, Tirrell PC. A successful experiment to reduce unnecessary laboratory use in a community hospital. Med Care. 1988; 26: 631-642.
33. Bunting PS, Walraven C. Effect of a controlled feedback intervention on laboratory test ordering by community physicians. Clin Chem. 2004; 50: 321-326
34. Thomas RE, Croal BL, Ramsay C, Eccles M, Grimshaw J. Effect of enhanced feedback and brief educational messages on laboratory test requesting in primary care: a cluster randomized trial. Lancet. 2006; 367: 1990-1996
35. Attali M, Barel Y, Somin M, Beilinson N, Shankman M, Ackerman A, et al. A cost-effective method for reducing the volume of laboratory tests in a university-associated teaching hospital. Mt Sinai J Med. 2006; 73: 787-794
36. Finegan BA, Rashiq S, McAlister FA, O'Connor P. Selective ordering of preoperative investigations by anesthesiologists reduces the number and cost of tests. Can J Anesth. 2005; 52: 575- 580
37. Hampers LC, Cha S, Gutglass DJ, Krug SE, Binns HJ. The effect of price information on test-ordering behavior and patient outcomes in a pediatric emergency department. Pediatrics. 1999; 103: 877-882
38. Bates DW, Kuperman GJ, Jha A, Teich J, Orav E, Ma'luf N, et al. Does the computerized display of charges affect inpatient ancillary test utilization? Arch Int Med. 1997; 157: 2501-2508
39. Bovier PA, Martin DP, Perneger TV. Cost-consciousness among Swiss doctors: a cross-sectional survey. BMC Health Serv Res. 2005; 5: 72